NCT01203774已完成4 期
"Comparison of SoloSTAR With a Syringe-administered Glargine Insulin in Diabetic Patients Discharged From the Hospital"
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 43
- 试验地点
- 1
- 主要终点
- HbA1c at Three Months of Each Period of Treatment
研究概览
简要总结
In this study the investigators would like to test the hypothesis that in diabetic patients discharged from the hospital, SoloSTAR Glargine insulin will be superior to syringe-injected Glargine in terms of diabetes control, compliance, and patient satisfaction and preference. The investigators will test this hypothesis in a randomized, crossover trial.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 22 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All patients with type 1 and 2 diabetes discharged from the hospital with recommendations to take Glargine
排除标准
- •Patients unwilling to participate and patients incapable of complying with the study regimen, such as patients with alcohol and drug addiction problems and patients with severe mental illness
研究组 & 干预措施
Syringe-administered vs pen-administered Glargine
Active Comparator
Syringe-administered Glargine insulin and then pen-administered Glargine insulin
干预措施: Glargine insulin (Drug)
Pen-administered vs syringe-admnistered Glargine
Active Comparator
SoloSTAR pen-administered Glargine insulin then syringe-administered Glargine insulin
干预措施: Glargine insulin (Drug)
结局指标
主要结局
HbA1c at Three Months of Each Period of Treatment
时间窗: Baseline, Month 3 (End of Intervention 1), Month 6 (End of intervention 2)
Data was collected by group
次要结局
- Compliance and Patient Satisfaction(6 months of treatment after discharge from the hospital)
研究者
研究点 (1)
Loading locations...
相似试验
终止
1 期
Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery LesionsPeripheral Vascular DiseasesNCT00489164Cordis US Corp.83
已完成
不适用
To Assess the Efficacy of Investigational Product on the Neuropathic Pain in Individuals Suffering From Type II Diabetes Mellitus.Diabetic NeuropathiesInsomnia Due to Medical ConditionNCT04504305Vedic Lifesciences Pvt. Ltd.64
已完成
不适用
ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)?Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1NCT01460446Hoffmann-La Roche218
已完成
不适用
Health-related Quality of Life and Psychosocial Aspects of Diabetes Technology (Insulin Pumps)T1DMHealth Related Quality of LifeInsulin PumpNCT04756011Ain Shams University60
已完成
1 期
Single Pass Albumin Dialysis in Patients With CirrhosisAcute on Chronic Hepatic FailureCirrhosisEncephalopathyHepatorenal SyndromeNCT00764049Assistance Publique - Hôpitaux de Paris11